Validation of Ventriject Determined Maximal Oxygen Uptake
Launched by UNIVERSITY OF COPENHAGEN · Apr 11, 2018
Trial Information
Current as of June 25, 2025
Completed
Keywords
ClinConnect Summary
this study will be composed of the following tests:
* blood sample for measurement of blood values
* blood pressure measurement to rule out risks affiliated with maximal effort testing
* DXA body composition scanning
* Measurement on ECG, echosonography and echoseismography with accelerometer, microphone and ECG wires
* Measurements with phone (iPhone)
* VO2 max assessment by maximal oxygen uptake testing on a training bike, using online oxygenmeasurement equipment
* Hand-grip strength assessment
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • - healthy adults between 18 and 45 years of age
- Exclusion Criteria:
- • current or previous cardiovascular disease
- • chronic use of medicine
- • pregnancy
- • illnesses which prohibits the testing of maximal oxygen uptake
About University Of Copenhagen
The University of Copenhagen, a leading research institution in Denmark, is dedicated to advancing medical knowledge and improving patient outcomes through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university leverages its expertise in various fields, including health sciences, pharmacology, and biotechnology, to design and conduct rigorous clinical studies. Committed to ethical standards and scientific integrity, the University of Copenhagen aims to contribute significantly to the global medical community by facilitating groundbreaking research that addresses pressing healthcare challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Copenhagen, , Denmark
Patients applied
Trial Officials
Jørn W Helge, Prof.
Principal Investigator
jhelge@sund.ku
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials